Viewing data from:

AMPICILLIN TRIHYDRATE

ANDA

AMPICILLIN/AMPICILLIN TRIHYDRATE | A060765 | IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA

2 strengths0 unique patents0 unique exclusivities

Medicare Part D Spending

CMS annual spending data for Ampicillin Trihydrate (2023)

Total Spending

$1.3M

Total Claims

88,047

Beneficiaries

67,296

Avg Cost/Unit

$0.49

Spending Trend

$1.7M(2019)→$1.5M(2020)→$1.5M(2021)→$1.4M(2022)→$1.3M(2023)

YoY Change:-1.7%

5yr CAGR:+1.4%

Source: CMS Medicare Part D Spending by Drug (2023). Shows gross drug cost under Part D.

Products (2)

Sort:

#001 — EQ 250MG BASE

0 patents0 exclusivities▴

CAPSULE;ORAL | Approved: Approved Prior to Jan 1, 1982

No patent or exclusivity listings for this strength.

#002 — EQ 500MG BASE

0 patents0 exclusivities▾

CAPSULE;ORAL | Approved: Approved Prior to Jan 1, 1982